David A. Santos - 04 Feb 2025 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Signature
/s/ Raymond Furey (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
04 Feb 2025
Net transactions value
-$83,836
Form type
4
Filing time
06 Feb 2025, 20:27:13 UTC
Previous filing
31 Jan 2025
Next filing
19 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale $44,457 -2,125 -3.8% $20.92 53,500 04 Feb 2025 Direct F1
transaction RIGL Common Stock Sale $39,379 -1,796 -3.4% $21.93 51,704 05 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.